Posted by Squiggles on May 8, 2006, at 6:01:41
In reply to Statistical question on SSRIs, posted by Squiggles on May 7, 2006, at 6:22:17
Here are some studies I found on PubMed on the
topic of comparing Reboxetine to Fluoxetine:http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=pubmed
It looks as good as, or even superiour to
both fluoxetine and imipramine. This is
a point for Healy, but it is also something
that interests me personally.If it is superiour, why isn't it available?
Why did the FDA nix it? I searched for
Pharmacia and Upjohn who have now been
bought or merged into Pfizer, but the
drug is still not available and without
a patent number.Any ideas, what's going on with a drug
that is superiour and unique for major
depression, and stashed on the shelves?
Maybe a typical bureaucratic problem,
or is this pharmapolitics?Thanks for any opinion. My friend is
willing to try it, if the present increase
in her imipramine dose does not work.Squiggles
poster:Squiggles
thread:640557
URL: http://www.dr-bob.org/babble/20060504/msgs/641226.html